Professor Andrew Whittaker, Professor Tom Davis
Dr Jeroen Goos, Dr Ruirui Qiao, Dr Cheng Zhang, Dr Changkui Fu, Dr Simon Puttick
We aim to improve the resolution and accuracy of molecular imaging at different physiological sites and to exploit nanotechnology for specific diagnosis and theranostic applications.
The Big Questions
- Can we monitor pathophysiological changes non-invasively by combining molecular imaging with bioresponsive nanoparticles?
- Can we exploit nanotechnology to increase the signal-tonoise ratio of existing molecular imaging probes?
- Can we develop novel tools for multimodality imaging by combining different imaging probes in a single molecular imaging agent?
Click here for more information.